Fingerprint
Dive into the research topics of 'The real-world cost-effectiveness of adjuvant trastuzumab in HER-2/neu-positive early breast cancer in Taiwan'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
The real-world cost-effectiveness of adjuvant trastuzumab in HER-2/neu-positive early breast cancer in Taiwan
Hui Chu Lang, Hsiao Wei Chen, Tzeon Jye Chiou, Agnes L.F. Chan
Research output: Contribution to journal › Article › peer-review
25
Citations
(Scopus)